These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 26518647)

  • 21. Curcumin prevents diabetic cardiomyopathy in streptozotocin-induced diabetic rats: possible involvement of PKC-MAPK signaling pathway.
    Soetikno V; Sari FR; Sukumaran V; Lakshmanan AP; Mito S; Harima M; Thandavarayan RA; Suzuki K; Nagata M; Takagi R; Watanabe K
    Eur J Pharm Sci; 2012 Oct; 47(3):604-14. PubMed ID: 22564708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of valsartan on diabetic cardiomyopathy in rats with type 2 diabetes mellitus.
    Yang ZH; Peng XD
    Chin Med J (Engl); 2010 Dec; 123(24):3640-3. PubMed ID: 22166644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Favorable effects of resveratrol on sympathetic neural remodeling in rats following myocardial infarction.
    Xin P; Pan Y; Zhu W; Huang S; Wei M; Chen C
    Eur J Pharmacol; 2010 Dec; 649(1-3):293-300. PubMed ID: 20869962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of resveratrol on nerve functions, oxidative stress and DNA fragmentation in experimental diabetic neuropathy.
    Kumar A; Kaundal RK; Iyer S; Sharma SS
    Life Sci; 2007 Mar; 80(13):1236-44. PubMed ID: 17289084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sirtuins: novel targets for metabolic disease in drug development.
    Jiang WJ
    Biochem Biophys Res Commun; 2008 Aug; 373(3):341-4. PubMed ID: 18577374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EGFR inhibition protects cardiac damage and remodeling through attenuating oxidative stress in STZ-induced diabetic mouse model.
    Liang D; Zhong P; Hu J; Lin F; Qian Y; Xu Z; Wang J; Zeng C; Li X; Liang G
    J Mol Cell Cardiol; 2015 May; 82():63-74. PubMed ID: 25758431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sirt 1 activator inhibits the AGE-induced apoptosis and p53 acetylation in human vascular endothelial cells.
    Li P; Zhang L; Zhou C; Lin N; Liu A
    J Toxicol Sci; 2015; 40(5):615-24. PubMed ID: 26354378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GLP-1 analog liraglutide protects against cardiac steatosis, oxidative stress and apoptosis in streptozotocin-induced diabetic rats.
    Inoue T; Inoguchi T; Sonoda N; Hendarto H; Makimura H; Sasaki S; Yokomizo H; Fujimura Y; Miura D; Takayanagi R
    Atherosclerosis; 2015 May; 240(1):250-9. PubMed ID: 25818251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipid metabolism and its implications for type 1 diabetes-associated cardiomyopathy.
    Ritchie RH; Zerenturk EJ; Prakoso D; Calkin AC
    J Mol Endocrinol; 2017 May; 58(4):R225-R240. PubMed ID: 28373293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between downregulation of miRNAs and increase of oxidative stress in the development of diabetic cardiac dysfunction: junctin as a target protein of miR-1.
    Yildirim SS; Akman D; Catalucci D; Turan B
    Cell Biochem Biophys; 2013; 67(3):1397-408. PubMed ID: 23723006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of prolyl hydroxylase 3 ameliorates cardiac dysfunction in diabetic cardiomyopathy.
    Xia Y; Gong L; Liu H; Luo B; Li B; Li R; Li B; Lv M; Pan J; An F
    Mol Cell Endocrinol; 2015 Mar; 403():21-9. PubMed ID: 25595486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The hyperglycemia stimulated myocardial endoplasmic reticulum (ER) stress contributes to diabetic cardiomyopathy in the transgenic non-obese type 2 diabetic rats: a differential role of unfolded protein response (UPR) signaling proteins.
    Lakshmanan AP; Harima M; Suzuki K; Soetikno V; Nagata M; Nakamura T; Takahashi T; Sone H; Kawachi H; Watanabe K
    Int J Biochem Cell Biol; 2013 Feb; 45(2):438-47. PubMed ID: 23032698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin and resveratrol act synergistically, preventing cardiac dysfunction in diabetes, but the advantage of resveratrol in diabetics with acute heart attack is antagonized by insulin.
    Huang JP; Huang SS; Deng JY; Chang CC; Day YJ; Hung LM
    Free Radic Biol Med; 2010 Dec; 49(11):1710-21. PubMed ID: 20828608
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FT23, an orally active antifibrotic compound, attenuates structural and functional abnormalities in an experimental model of diabetic cardiomyopathy.
    Tan SM; Zhang Y; Wang B; Tan CY; Zammit SC; Williams SJ; Krum H; Kelly DJ
    Clin Exp Pharmacol Physiol; 2012 Aug; 39(8):650-6. PubMed ID: 22612418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kalpaamruthaa modulates oxidative stress in cardiovascular complication associated with type 2 diabetes mellitus through PKC-β/Akt signaling.
    Latha R; Shanthi P; Sachdanandam P
    Can J Physiol Pharmacol; 2013 Nov; 91(11):901-12. PubMed ID: 24117257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Attenuation of insulin resistance, metabolic syndrome and hepatic oxidative stress by resveratrol in fructose-fed rats.
    Bagul PK; Middela H; Matapally S; Padiya R; Bastia T; Madhusudana K; Reddy BR; Chakravarty S; Banerjee SK
    Pharmacol Res; 2012 Sep; 66(3):260-8. PubMed ID: 22627169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined metoprolol and ascorbic acid treatment prevents intrinsic damage to the heart during diabetic cardiomyopathy.
    Saran V; Sharma V; Wambolt R; Yuen VG; Allard M; McNeill JH
    Can J Physiol Pharmacol; 2014 Oct; 92(10):827-37. PubMed ID: 25229873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury.
    Noh H; Oh EY; Seo JY; Yu MR; Kim YO; Ha H; Lee HB
    Am J Physiol Renal Physiol; 2009 Sep; 297(3):F729-39. PubMed ID: 19553350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment with low-dose resveratrol reverses cardiac impairment in obese prone but not in obese resistant rats.
    Louis XL; Thandapilly SJ; MohanKumar SK; Yu L; Taylor CG; Zahradka P; Netticadan T
    J Nutr Biochem; 2012 Sep; 23(9):1163-9. PubMed ID: 22137269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of rosiglitazone on the expression of cardiac adiponectin receptors and NADPH oxidase in type 2 diabetic rats.
    Guo Z; Qin Z; Zhang R; Li J; Yin Y
    Eur J Pharmacol; 2012 Jun; 685(1-3):116-25. PubMed ID: 22542658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.